[Adjuvant and neoadjuvant methods: what is their value--do they change surgical procedure?].

H.-J. Meyer(Medizinische Hochschule Hannover), R Pichlmayr, J. Jähne, Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), H. Wilke(Heidelberg University)

PubMed

January 1, 1996

Cited by 0

Related Papers

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

|Journal of Clinical Oncology|2010|714

Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis

|Genes & Development|2009|351

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

|The Lancet. Gastroenterology & hepatology|2020|202

Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L

|The EMBO Journal|2011|179

Hsp90 is regulated by a switch point in the C‐terminal domain

|EMBO Reports|2009|173